UNSPSC 51287005: Diathymosulfone

This classification denotes a sulfone anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UK27RQ38IX. European Medicines Agency schedules Diathymosulfone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07067MIG. Diathymosulfone generally arises in the molecular formula C32H34N4O4S.

The term DIATHYMOSULFONE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, volume 16, no. 3 1962, list 4.) DIATHYMOSULFONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: S(=O)(=O)(C1CCC(N/N=C2/C=C(C(C)C)C(=O)C=C2C)CC1)C1CCC(N/N=C2\C=C(C(C)C)C(=O)C=C2C)CC1.

UNSPSC 51287005 Diathymosulfone is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The source shows no opportunities for diathymosulfone procurement; instead, the four tagged opportunities address naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas HHS Commission), medical and first aid supplies (City of Tampa), and generic multi-source pharmaceuticals and OTC products (Minnesota Multistate Cooperative Purchasing Alliance). These solicitations span emergency medical supplies, pharmacy benefit management, and pharmaceutical distribution — categories that fall outside the diathymosulfone commodity scope. The issuing bodies include a county health department, a state health commission, a municipal fire department, and a cooperative purchasing alliance, indicating activity across county, state, and municipal jurisdictions. No recent solicitations for diathymosulfone itself appear in the available records.

Activity under this code shows geographic spread across Florida, Texas, Minnesota, and Oregon, driven primarily by cooperative purchasing and state health commission procurement. Representative opportunities include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023), the City of Tampa's sealed-bid solicitation for medical and first aid supplies designated as sheltered for Small Local Business Enterprises with an estimated contract value of $700,000 (due March 13, 2026), and the Minnesota Department of Administration's RFP for generic pharmaceuticals and OTC products through MMCAP with responses due March 26, 2026. The Texas HHS Commission RFI on direct-to-manufacturer prescriptions (due April 3, 2026) represents exploratory procurement rather than a formal competitive solicitation. The code's recent tagging appears to reflect a mismatch between the nominal commodity and the actual procurement activity, suggesting the code may require verification or that diathymosulfone procurement is not currently active in the state and local market.